TransCode Therapeutics, Inc. (RNAZ)
NASDAQ: RNAZ · Real-Time Price · USD
9.88
-0.11 (-1.05%)
Feb 26, 2026, 3:00 PM EST - Market open
TransCode Therapeutics Market Cap
TransCode Therapeutics has a market cap or net worth of $9.06 million as of February 26, 2026. Its market cap has increased by 31.90% in one year.
Market Cap
9.06M
Enterprise Value
6.32M
1-Year Change
31.90%
Ranking
Category
Stock Price
$9.88
Market Cap Chart
Since the IPO on July 9, 2021, TransCode Therapeutics's market cap has decreased from $47.87M to $9.06M, a decrease of -81.08%. That is a compound annual growth rate of -30.18%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 25, 2026 | 9.15M | 46.12% |
| Dec 31, 2025 | 6.26M | 166.92% |
| Dec 31, 2024 | 2.35M | -43.27% |
| Dec 29, 2023 | 4.14M | -51.10% |
| Dec 30, 2022 | 8.46M | -73.50% |
| Dec 31, 2021 | 31.92M | -33.32% |
| Jul 9, 2021 | 47.87M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Bolt Biotherapeutics | 9.54M |
| NuCana | 9.45M |
| BioVie | 9.44M |
| Chemomab Therapeutics | 8.99M |
| GridAI Technologies | 8.94M |
| SeaStar Medical Holding | 8.72M |
| Cardio Diagnostics Holdings | 8.69M |
| CollPlant Biotechnologies | 8.64M |